Logo image of CLSK

CLEANSPARK INC (CLSK) Stock Fundamental Analysis

NASDAQ:CLSK - Nasdaq - US18452B2097 - Common Stock - Currency: USD

10.225  -0.5 (-4.62%)

Fundamental Rating

4

Overall CLSK gets a fundamental rating of 4 out of 10. We evaluated CLSK against 282 industry peers in the Software industry. While CLSK seems to be doing ok healthwise, there are quite some concerns on its profitability. CLSK is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CLSK was profitable.
CLSK had a negative operating cash flow in the past year.
In the past 5 years CLSK always reported negative net income.
In the past 5 years CLSK reported 4 times negative operating cash flow.
CLSK Yearly Net Income VS EBIT VS OCF VS FCFCLSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.36%, CLSK is in line with its industry, outperforming 43.62% of the companies in the same industry.
CLSK has a Return On Equity (-10.34%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -7.36%
ROE -10.34%
ROIC N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
CLSK Yearly ROA, ROE, ROICCLSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

With a Gross Margin value of 51.98%, CLSK is not doing good in the industry: 65.96% of the companies in the same industry are doing better.
CLSK's Gross Margin has improved in the last couple of years.
CLSK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
CLSK Yearly Profit, Operating, Gross MarginsCLSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

4

2. Health

2.1 Basic Checks

CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLSK has been increased compared to 1 year ago.
CLSK has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CLSK is higher compared to a year ago.
CLSK Yearly Shares OutstandingCLSK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CLSK Yearly Total Debt VS Total AssetsCLSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.62 indicates that CLSK is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.62, CLSK perfoms like the industry average, outperforming 56.38% of the companies in the same industry.
CLSK has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
CLSK has a Debt to Equity ratio of 0.34. This is in the lower half of the industry: CLSK underperforms 60.99% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.62
ROIC/WACCN/A
WACC10.32%
CLSK Yearly LT Debt VS Equity VS FCFCLSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 8.67 indicates that CLSK has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 8.67, CLSK belongs to the top of the industry, outperforming 93.62% of the companies in the same industry.
CLSK has a Quick Ratio of 8.67. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
CLSK has a better Quick ratio (8.67) than 93.62% of its industry peers.
Industry RankSector Rank
Current Ratio 8.67
Quick Ratio 8.67
CLSK Yearly Current Assets VS Current LiabilitesCLSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

CLSK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 337.93%, which is quite impressive.
The Revenue has grown by 125.03% in the past year. This is a very strong growth!
CLSK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 142.70% yearly.
EPS 1Y (TTM)337.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%490%
Revenue 1Y (TTM)125.03%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%90.8%

3.2 Future

The Earnings Per Share is expected to grow by 138.13% on average over the next years. This is a very strong growth
CLSK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 37.95% yearly.
EPS Next Y911.01%
EPS Next 2Y249.02%
EPS Next 3Y138.13%
EPS Next 5YN/A
Revenue Next Year90.15%
Revenue Next 2Y64.08%
Revenue Next 3Y37.95%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CLSK Yearly Revenue VS EstimatesCLSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CLSK Yearly EPS VS EstimatesCLSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

CLSK is valuated correctly with a Price/Earnings ratio of 14.82.
Based on the Price/Earnings ratio, CLSK is valued cheaply inside the industry as 84.04% of the companies are valued more expensively.
CLSK is valuated rather cheaply when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.99, which indicates a very decent valuation of CLSK.
CLSK's Price/Forward Earnings ratio is rather cheap when compared to the industry. CLSK is cheaper than 88.65% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CLSK to the average of the S&P500 Index (35.28), we can say CLSK is valued rather cheaply.
Industry RankSector Rank
PE 14.82
Fwd PE 11.99
CLSK Price Earnings VS Forward Price EarningsCLSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CLSK's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CLSK is cheaper than 78.01% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.64
CLSK Per share dataCLSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

CLSK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLSK's earnings are expected to grow with 138.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y249.02%
EPS Next 3Y138.13%

More info and screens

0

5. Dividend

5.1 Amount

CLSK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEANSPARK INC

NASDAQ:CLSK (8/8/2025, 3:26:08 PM)

10.225

-0.5 (-4.62%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-12 2025-08-12/amc
Inst Owners62.29%
Inst Owner Change-0.41%
Ins Owners2.28%
Ins Owner Change-3.07%
Market Cap2.87B
Analysts82.35
Price Target20.17 (97.26%)
Short Float %23.57%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DP-4.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-153.14%
Min EPS beat(2)-403.92%
Max EPS beat(2)97.65%
EPS beat(4)1
Avg EPS beat(4)-174.62%
Min EPS beat(4)-403.92%
Max EPS beat(4)97.65%
EPS beat(8)4
Avg EPS beat(8)35.95%
EPS beat(12)6
Avg EPS beat(12)3.83%
EPS beat(16)6
Avg EPS beat(16)-62.8%
Revenue beat(2)1
Avg Revenue beat(2)-1.35%
Min Revenue beat(2)-7.4%
Max Revenue beat(2)4.69%
Revenue beat(4)1
Avg Revenue beat(4)-2.98%
Min Revenue beat(4)-7.95%
Max Revenue beat(4)4.69%
Revenue beat(8)3
Avg Revenue beat(8)-1.1%
Revenue beat(12)4
Avg Revenue beat(12)-2.59%
Revenue beat(16)4
Avg Revenue beat(16)-6.64%
PT rev (1m)-1.73%
PT rev (3m)-1.81%
EPS NQ rev (1m)-14.29%
EPS NQ rev (3m)11.75%
EPS NY rev (1m)-1.53%
EPS NY rev (3m)-31.66%
Revenue NQ rev (1m)0.58%
Revenue NQ rev (3m)-11.76%
Revenue NY rev (1m)-1.21%
Revenue NY rev (3m)-6.97%
Valuation
Industry RankSector Rank
PE 14.82
Fwd PE 11.99
P/S 5.35
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB 1.64
EV/EBITDA 24.64
EPS(TTM)0.69
EY6.75%
EPS(NY)0.85
Fwd EY8.34%
FCF(TTM)-2.08
FCFYN/A
OCF(TTM)-1.36
OCFYN/A
SpS1.91
BVpS6.73
TBVpS6.23
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.36%
ROE -10.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.98%
FCFM N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
F-Score1
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 4.45
Cap/Depr 85.18%
Cap/Sales 37.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.67
Quick Ratio 8.67
Altman-Z 2.62
F-Score1
WACC10.32%
ROIC/WACCN/A
Cap/Depr(3y)65.93%
Cap/Depr(5y)337.91%
Cap/Sales(3y)31.8%
Cap/Sales(5y)89.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)337.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%490%
EPS Next Y911.01%
EPS Next 2Y249.02%
EPS Next 3Y138.13%
EPS Next 5YN/A
Revenue 1Y (TTM)125.03%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%90.8%
Revenue Next Year90.15%
Revenue Next 2Y64.08%
Revenue Next 3Y37.95%
Revenue Next 5YN/A
EBIT growth 1Y-47.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year994.95%
EBIT Next 3Y134.9%
EBIT Next 5YN/A
FCF growth 1Y-2529.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1149.55%
OCF growth 3YN/A
OCF growth 5YN/A